Top

Surgical Instrument Repair

Expired

FA5000-20-R-0004Federal

Response Deadline

11/20/2019, 12:00:00 AM UTC

General Info

Agency

Department Of Defense → FA5000 673 Cons Lgc

View Agency

NAICS

811219 - NAICS Code 811219

View NAICS

Place of Performance

5955 ZEAMER AVE, JBER, AK, 99506, USA

Set-Aside

NONE

Documents(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

1 update

PhaseClosed

PostedNov 7

Combined Synopsis

Amendment 1Nov 7

Contract was updated

Response DeadlineNov 20

Deadline has passed

Response Deadline

11/20/2019, 12:00:00 AM UTC

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → FA5000 673 Cons Lgc

Contacts2 people available

OfficeJBER, AK, 99506-2501, USA

Organization / Agency

Department Of Defense → FA5000 673 Cons Lgc

View Agency Profile

Office Address

JBER, AK, 99506-2501, USA

Contacts

2 contacts available

View Contacts

Start a free trial to view contact information.

Start Free Trial

Similar Contracts

NAICS: 811219

New

Federal

DGMT service contract on PacBio Revio sequencer

The contract pertains to a service agreement for the PacBio Revio next-generation sequencing (NGS) instrument under the Defense Genomic and Medical Technology (DGMT) program. It is a forecast notice issued by the Food and Drug Administration (FDA) and relates to maintenance and support services for the PacBio Revio sequencer, which plays a crucial role in advanced genomic research and medical applications. Although specific location details and set-aside classifications are not provided, the contract falls under the NAICS code 811219, which covers other electronic and precision equipment repair and maintenance. Key points include the involvement of the FDA as the contracting agency, emphasizing the instrument’s importance in regulatory and research activities. The contract’s point of contact is listed as the Nctr Acquisition Liaison with an email provided for inquiries, while the contracting officer remains to be determined. The service contract is part of planned procurement activities intended to ensure the PacBio Revio sequencer remains fully operational and reliable for ongoing projects involving high-throughput genetic sequencing.

Food And Drug Administration

POSTED

about 12 hours ago

DEADLINE

N/A

Service contract for Illumina Miseq - new compete

The contract involves securing service support for the Illumina Miseq sequencing system, aimed at ensuring its optimal operation and maintenance. This upcoming opportunity, forecasted by the Food and Drug Administration, falls under the NAICS code 811219, which covers other electronic and precision equipment repair and maintenance services. The initiative reflects the agency’s effort to sustain critical laboratory technology infrastructure. While specific location details and the contracting officer’s information are yet to be finalized, interested parties can direct inquiries to the Cber Acquisition Liaison via the provided email. This contract is in the forecasting stage as of March 11, 2026, indicating preparation for solicitation, and is important for companies specializing in life science equipment servicing to monitor.

Food And Drug Administration

POSTED

about 12 hours ago

DEADLINE

N/A

calibration and required service of BD X-20 LSR Fortessa.

The contract involves the calibration and required servicing of the BD X-20 LSR Fortessa, a specialized laboratory instrument. The initial contract for fiscal year 2025 is identified with CIN OVRR-25-C-1339, referencing requisition number 1282891 and purchase order 75F40124P00008, tied to the unit with serial number H656385001. The period of performance for this base contract spans from November 27, 2025, through November 26, 2026. Additionally, the contract includes an option to exercise a second year (OY2) for fiscal year 2026, indicating potential continuity of service beyond the initial term. The contract is managed under the Food and Drug Administration, specifically by the CBER Acquisition Liaison as the program point of contact. The work is categorized under NAICS code 811219, which relates to specialized maintenance and repair services. While specific location details for performance are not provided, the contract remains open with a contracting officer yet to be designated. Contact for inquiries is available via the FDA's acquisition email, and further information is accessible through the FDA’s industry opportunity forecast platform.

Food And Drug Administration

POSTED

about 12 hours ago

DEADLINE

N/A

DGMT service contract on PacBio Revio sequencer

The contract involves a service agreement for the PacBio Revio next-generation sequencing (NGS) instrument, with a base period and the possibility of up to three additional option periods. It is intended to support the Food and Drug Administration (FDA) in maintaining and servicing this specialized sequencing equipment, ensuring its operational readiness and performance for research and regulatory activities. The contract falls under the NAICS code 811219, which corresponds to specialized machinery and equipment repair services. The forecasted contract was posted on March 11, 2026, and includes coordination through FDA acquisition points of contact, with a designated program liaison and a contracting officer yet to be determined. Although specific location and budget details are not provided, the service is critical to maintaining advanced sequencing capabilities within the FDA. Interested parties are encouraged to reach out via the FDA acquisition email provided for further information and opportunities related to this procurement.

Food And Drug Administration

POSTED

about 12 hours ago

DEADLINE

N/A

DBPAP // Monolith NT.115 microscale thermophoresis (MA)

The contract pertains to the procurement and maintenance of the Monolith NT.115 microscale thermophoresis instrument, a specialized device used for molecular interaction analysis. It involves a maintenance agreement covering a base year along with optional renewal years, specifically noted for fiscal years 2023 and 2024 under contract numbers C-1235 and C-1083, respectively. The contract is managed by the Food and Drug Administration (FDA), under the NAICS code 811219, which typically covers equipment maintenance and repair services. This engagement is a forecasted opportunity focused on ensuring the ongoing operational reliability and support for the Monolith NT.115 instrument. The contact details identify a program acquisition liaison within the FDA as well as an unspecified contracting officer who will oversee the execution of the maintenance agreement. The purchase and service arrangement reflects the FDA's commitment to maintaining critical scientific instruments necessary for its regulatory and research functions.

Food And Drug Administration

POSTED

about 12 hours ago

DEADLINE

N/A

View Details